CARE-ID
Research ServicesVirginia, United States2-10 Employees
CARE-ID conducts clinical trials for numerous pharmaceutical and government organizations. Investigators have directed over 100 trials ranging from Phase 1 to Phase IV.
Strategic Partnership Growth CARE-ID's recent collaboration with Gilead Sciences highlights their capability to partner with major players in the pharmaceutical industry, presenting opportunities to expand their strategic alliances and co-develop innovative treatments.
Niche Clinical Expertise Specializing in clinical trials across all phases for pharmaceutical and government clients positions CARE-ID to attract projects that require flexible, expert research services in complex trial management.
Technology-Driven Research Utilization of modern web technologies like React, Google Maps, and Shopify indicates a focus on efficient operations and engaging client communication, which can be leveraged to improve service delivery and outreach.
Growth Potential in Focus Areas Given their involvement in HIV treatment innovation, CARE-ID can target emerging therapeutic areas and secure contracts in niche markets demanding specialized clinical research.
Competitive Positioning Operating with a small team and revenue under 1 million USD suggests agility and personalized services, which can be emphasized in marketing efforts to attract clients seeking dedicated research partners.
CARE-ID uses 8 technology products and services including Google Hosted Libraries, Open Graph, Shopify, and more. Explore CARE-ID's tech stack below.
| CARE-ID Email Formats | Percentage |
| FLast@careidresearch.com | 50% |
| FLast@careidresearch.com | 50% |
Research ServicesVirginia, United States2-10 Employees
CARE-ID conducts clinical trials for numerous pharmaceutical and government organizations. Investigators have directed over 100 trials ranging from Phase 1 to Phase IV.
CARE-ID's revenue is estimated to be in the range of $1M
CARE-ID's revenue is estimated to be in the range of $1M